GHP Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.18M Hold
1,816
0.08% 233
2026
Q1
$1.67M Buy
1,816
+86
+5% +$87.2K 0.07% 245
2025
Q4
$1.86M Hold
1,730
0.08% 237
2025
Q3
$1.32M Buy
1,730
+2
+0.1% +$1.49K 0.06% 256
2025
Q2
$1.35M Hold
1,728
0.06% 249
2025
Q1
$1.43M Sell
1,728
-108
-6% -$89.9K 0.07% 245
2024
Q4
$1.42M Sell
1,836
-12
-0.6% -$9.94K 0.07% 246
2024
Q3
$1.64M Buy
1,848
+89
+5% +$80K 0.08% 241
2024
Q2
$1.59M Buy
1,759
+5
+0.3% +$4K 0.08% 242
2024
Q1
$1.36M Sell
1,754
-938
-35% -$668K 0.07% 254
2023
Q4
$1.57M Sell
2,692
-932
-26% -$544K 0.08% 237
2023
Q3
$2.21M Sell
3,624
-1,062
-23% -$547K 0.13% 202
2023
Q2
$2.48M Sell
4,686
-322
-6% -$135K 0.14% 202
2023
Q1
$1.72M Buy
5,008
+3,790
+311% +$1.28M 0.11% 225
2022
Q4
$446K Sell
1,218
-6
-0.5% -$2.13K 0.03% 308
2022
Q3
$396K Sell
1,224
-38
-3% -$12K 0.03% 303
2022
Q2
$409K Buy
1,262
+3
+0.2% +$901 0.03% 299
2022
Q1
$360K Sell
1,259
-44
-3% -$11.3K 0.02% 306
2021
Q4
$360K Buy
1,303
+1
+0.1% +$254 0.03% 268
2021
Q3
$301K Sell
1,302
-1,934
-60% -$477K 0.02% 267
2021
Q2
$743K Sell
3,236
-201
-6% -$40.4K 0.06% 211
2021
Q1
$642K Buy
3,437
+301
+10% +$58.9K 0.06% 216
2020
Q4
$530K Sell
3,136
-49
-2% -$7.32K 0.05% 217
2020
Q3
$471K Buy
3,185
+51
+2% +$7.89K 0.05% 218
2020
Q2
$515K Hold
3,134
0.06% 219
2020
Q1
$435K Buy
3,134
+1
+0% +$137 0.07% 226
2019
Q4
$412K Buy
3,133
+1
+0% +$116 0.04% 249
2019
Q3
$350K Buy
3,132
+1
+0% +$111 0.04% 254
2019
Q2
$347K Sell
3,131
-39
-1% -$4.59K 0.04% 257
2019
Q1
$411K Buy
+3,170
New +$385K 0.05% 237

Other funds holding LLY

GHP Investment Advisors's LLY Position: Q2 2026 in Review

GHP Investment Advisors held its Eli Lilly (LLY) position steady in Q2 2026 at 1,816 shares worth $2.18M. The position accounts for 0.08% of the portfolio, ranked #233.

GHP Investment Advisors first reported a position in LLY in Q1 2019 and has held it in 30 quarters since. The position peaked at $2.48M in Q2 2023. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • GHP Investment Advisors held 1,816 shares of Eli Lilly worth $2.18M as of Q2 2026.
  • GHP Investment Advisors left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.08% of GHP Investment Advisors's portfolio in Q2 2026, its #233 holding.
  • GHP Investment Advisors first reported a position in Eli Lilly in Q1 2019 and has held it in 30 quarters since.
  • GHP Investment Advisors's Eli Lilly position peaked at $2.48M in Q2 2023.
  • 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.